Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.74
0.232.42%
Last update: Dec 15, 9:05 AM
Comments
Loading...
TransCode Therapeutics (RNAZ) Stock Price, Quote, News & History
RNAZNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy TransCode Therapeutics (RNAZ) stock?
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Who are TransCode Therapeutics (RNAZ) competitors?
Other companies in TransCode Therapeutics’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) and Bolt Biotherapeutics Inc (NASDAQ:BOLT).
What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?
TransCode Therapeutics has a consensus price target of $10.00.
What is the current price for TransCode Therapeutics (RNAZ)?
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $9.7405 last updated December 15, 2025 at 9:05 AM EST.
Does TransCode Therapeutics (RNAZ) pay a dividend?
There are no upcoming dividends for TransCode Therapeutics.
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics does not have any upcoming earnings scheduled.
Is TransCode Therapeutics (RNAZ) going to split?
There is no upcoming split for TransCode Therapeutics.
What sector and industry does TransCode Therapeutics (RNAZ) operate in?
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
